Chinweze Ahaghotu has been at Bristol-Myers Squibb in Princeton, NJ since 2007, and has held various roles in corporate strategy, commercialization, finance, as well as research and development (R&D). He is currently leading the strategic planning for the R&D integration of the planned Celgene acquisition. Chinweze began his career as a discovery scientist at Merck investigating novel diabetes therapeutics, and has also worked in life sciences business development and venture capital. He serves on the Board of Directors of Henry J. Austin Health Center in Trenton, NJ; and lives with his wife, Jennifer, and two daughters in Yardley, PA.
High school: Coolidge Senior High School
Harvard UniversityCambridge, MA
|2001||A.B. Biology - Biophysics|
Pennsylvania State UniversityUniversity Park, PA
|2004||M.S. Information Systems|
Columbia UniversityNew York, NY
|2007||M.B.A. Business Administration|